Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

Does the QB have explicit and higher PPS requirements than “the pinks”? That’s all most people care about—no matter what they may say. Folks are here (and in every other equity market for that matter) to make money. This equity is going definitively in the WRONG DIRECTION—despite the fact that commercialization is (and had been) in full swing for 6+ months by a CONSERVATIVE reckoning, with the company, moreover, expecting to generate revenues sufficient to sustain operations beginning in the second half of THIS YEAR. Meantime Medistem, a firm established and grown by many of the same principals as established CELZ, was NOWHERE NEAR commercialization—and yet was bought out for $1.35/share, having risen to $2+ PPS at its height. In the words of the old computer system: “Does not compute.”